Octreotide
- 1 September 2006
- journal article
- review article
- Published by Springer Publishing Company in Neonatal Network
- Vol. 25 (5) , 365-369
- https://doi.org/10.1891/0730-0832.25.5.365
Abstract
A CHYLOTHORAX IS CHARACTERIZED BY AN ACCUMULATION OF pleural fluid having a turbid or milky white appearance due to a high lipid and triglyceride content. This continuously draining fluid, called chyle, contains lymphocytes, proteins, and immunoglobulins. Besides incurring respiratory compromise, the loss of fluid through excessive chyle drainage may lead to nutritional, electrolyte, and immunologic complications and is associated with high morbidity and prolonged hospitalization.1Chylothoraces may be acquired from trauma secondary to intraoperative disruption of either the thoracic duct lymph or its lymphatic tributary or from nontraumatic causes such as malignancies.Keywords
This publication has 18 references indexed in Scilit:
- Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: Is it safe?Pediatric Critical Care Medicine, 2004
- Treatment of Chylothorax in a Premature Infant Using SomatostatinJournal of Perinatology, 2003
- CONGENITAL CHYLOTHORAXAmerican Journal of Perinatology, 2000
- Etiology and management of pediatric chylothoraxThe Journal of Pediatrics, 2000
- Can Octreotide Be Added to Parenteral Nutrition Solutions? Point—CounterpointNutrition in Clinical Practice, 1998
- OctreotideNew England Journal of Medicine, 1996
- The Management of ChylothoraxChest, 1992
- 101 GROWTH IN A GIRL WITH NESIDIOBLASTOSIS DURING AND AFTER TEATMENT WITH THE SOMATOSTATIN ANALOGUE: SMS 201–995Pediatric Research, 1988
- SomatostatinNew England Journal of Medicine, 1983
- SomatostatinNew England Journal of Medicine, 1983